Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Milatovic, D.
Right arrow Articles by Fluit, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milatovic, D.
Right arrow Articles by Fluit, A. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Journal of Antimicrobial Chemotherapy (2002) 50, 293-299
© 2002 The British Society for Antimicrobial Chemotherapy

Correspondence

In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe

Dana Milatovic*, Franz-Josef Schmitz, Jan Verhoef and Ad C. Fluit

Eijkman-Winkler Institute for Medical Microbiology, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands

The first 10% of the full text of this article appears below.

Sir,

Faropenem is a new member of the penem class intended for oral administration. Penems share structural similarities with both penicillins and cephalosporins. Preliminary reports indicate that faropenem has a broad spectrum of activity against Gram-positive and -negative bacteria, and is also bactericidal.1,2

The purpose of the present study was to evaluate the in vitro activity of faropenem against a large number of recent clinical isolates from various European countries and to compare its activity with that of other orally administered compounds, such as co-amoxiclav, . . . [Full Text of this Article]

Acknowledgements


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
J. P Gettig, C. W Crank, and A. H Philbrick
Faropenem Medoxomil
Ann. Pharmacother., January 1, 2008; 42(1): 80 - 90.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
S. Mushtaq, R. Hope, M. Warner, and D. M. Livermore
Activity of faropenem against cephalosporin-resistant Enterobacteriaceae
J. Antimicrob. Chemother., May 1, 2007; 59(5): 1025 - 1030.
[Abstract] [Full Text] [PDF]